Clinical Trials
53 trialsRadiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery
Radiation Therapy Oncology Group
STARTRK-2
Hoffmann-La Roche
Smoking Cessation Treatment for Head & Neck Cancer Patients
M.D. Anderson Cancer Center
Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies
Presage Biosciences
First Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma Patients
Wake Forest University Health Sciences
A Platform Study of Novel Immunotherapy Combinations as First-Line Treatment in Participants With PD-L1 Positive Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck- GALAXIES H&N-202
GlaxoSmithKline
Sensor-Assisted Prevention of Dehydration in Head and Neck Cancer Patients
M.D. Anderson Cancer Center
Magnetic Resonance (MR) Imaging & Blood Biomarkers for Head and Neck Cancer
M.D. Anderson Cancer Center
3D Specimen Maps for RT Planning
Vanderbilt University Medical Center
OvAR-Y
Washington University School of Medicine
MK-3475-689
Merck Sharp & Dohme LLC
Axoguard HA Plus Nerve Protector to Reduce Post-operative Neck and Shoulder Dysfunction in Patients Undergoing Neck Dissection
University of Pittsburgh
QUADSHOT
University of Oklahoma
HexAgon-HN
Inhibrx Biosciences, Inc
MAGE-A4ᶜ¹º³²T for Multi-Tumor
USWM, LLC (dba US WorldMeds)
Comparing Two Ways to Manage Head and Neck Lymphedema
Abramson Cancer Center at Penn Medicine
CACTUX
Washington University School of Medicine
Phase II Trial of Adjuvant Cisplatin and Radiation With Pembrolizumab in Resected Head and Neck Squamous Cell Carcinoma
University of Cincinnati
Safety and Tolerability of the Use of Copaiba in Patients With Oral Cancer Submitted to Radiotherapy
Instituto Nacional de Cancer, Brazil
RadiomicArt
Istituto Clinico Humanitas
ELEPHAS-02
Elephas
MARTHA
University of Zurich
Ipilimumab for Head and Neck Cancer Patients
Providence Health & Services
TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers
University of Chicago
Pilot Study of Imatinib Cetuximab Combo for H & N Cancer
University of Wisconsin, Madison
Supportive Oncology Care At Home RCT
Massachusetts General Hospital
Evaluation of Improved Onboard Patient Imaging
Varian, a Siemens Healthineers Company
innovaTV 207
Seagen Inc.
Controlled Trial Of Acupuncture To Prevent Radiation-Induced Xerostomia
M.D. Anderson Cancer Center
Cough, Expiratory Training, and Chronic Aspiration After Head and Neck Radiotherapy
M.D. Anderson Cancer Center
LIBRETTO-001
Eli Lilly and Company
OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell Cancer
M.D. Anderson Cancer Center
Dyadic Yoga Intervention for Patient With Head and Neck Cancer Undergoing Radiotherapy and Their Family Caregivers
M.D. Anderson Cancer Center
HN-STAR
Wake Forest University Health Sciences
ProvoxLife Adoption Trends for Heat-Moisture Exchanger
M.D. Anderson Cancer Center
Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
National Cancer Institute (NCI)
A Study to Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)
Astellas Pharma Inc
Neoadjuvant Immunoradiotherapy in Head & Neck Cancer (NIRT 2-HNC)
Providence Health & Services
ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS)
USWM, LLC (dba US WorldMeds)
A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2
Seagen Inc.
Spirulina-Derived Product Alleviates Oral Mucositis in Patients Undergoing Radiotherapy for Malignant Head and Neck Tumors
West China Hospital
A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers
National Institutes of Health Clinical Center (CC)
VERSATILE-003
PDS Biotechnology Corp.
NT219 Combined With Standard of Care Biologic Therapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
University of Colorado, Denver
ChatBot and Activity Monitoring in Patients Undergoing Chemoradiotherapy
Abramson Cancer Center at Penn Medicine
Rambro2
Washington University School of Medicine
Study of Retinfanlimab in Combination With INCAGN02385 and INCAGN02390 as First-Line Treatment in Participants With PD-L1-Positive (CPS ≥ 1) Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
Incyte Corporation
TABAC STOP ORL
Centre Oscar Lambret
INTERLINK-1
AstraZeneca
Hypofractionated Preoperative Radiation for Head and Neck Cancers (HyPR-HN)
Medical College of Wisconsin